These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 21157201

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic value of bone scintigraphy in cancer patients with osteonecrosis of the jaw: is there something missing?
    Hakim SG.
    Clin Nucl Med; 2012 Sep; 37(9):874. PubMed ID: 22885823
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.
    Raje N, Woo SB, Hande K, Yap JT, Richardson PG, Vallet S, Treister N, Hideshima T, Sheehy N, Chhetri S, Connell B, Xie W, Tai YT, Szot-Barnes A, Tian M, Schlossman RL, Weller E, Munshi NC, Van Den Abbeele AD, Anderson KC.
    Clin Cancer Res; 2008 Apr 15; 14(8):2387-95. PubMed ID: 18413829
    [Abstract] [Full Text] [Related]

  • 7. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw.
    Dore F, Filippi L, Biasotto M, Chiandussi S, Cavalli F, Di Lenarda R.
    J Nucl Med; 2009 Jan 15; 50(1):30-5. PubMed ID: 19091894
    [Abstract] [Full Text] [Related]

  • 8. Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging.
    Okui T, Kobayashi Y, Tsujimoto M, Satoh K, Toyama H, Matsuo K.
    Ann Nucl Med; 2020 Sep 15; 34(9):620-628. PubMed ID: 32557015
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ early.
    Yamamoto Y, Mitsunaga S, Horikawa A, Hino A, Kurihara H.
    Ann Nucl Med; 2020 Jan 15; 34(1):74-79. PubMed ID: 31705367
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.
    Watanabe S, Nakajima K, Mizokami A, Yaegashi H, Noguchi N, Kawashiri S, Inokuchi M, Kinuya S.
    Ann Nucl Med; 2017 Apr 15; 31(3):201-210. PubMed ID: 27995542
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of SPECT/CT in the assessment of inflammatory jaw pathologies.
    Modabber A, Schick D, Möhlhenrich SC, Mottaghy FM, Verburg FA, Hölzle F, Gerressen M.
    Eur J Radiol; 2020 Apr 15; 125():108917. PubMed ID: 32120276
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Natural history of osteonecrosis of the jaw in patients with multiple myeloma.
    Badros A, Terpos E, Katodritou E, Goloubeva O, Kastritis E, Verrou E, Zervas K, Baer MR, Meiller T, Dimopoulos MA.
    J Clin Oncol; 2008 Dec 20; 26(36):5904-9. PubMed ID: 19018084
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.
    Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas I, Koloutsos GE, Teleioudis Z, Kitikidou K, Paraskevopoulos P, Zervas K, Antoniades K.
    J Clin Oncol; 2009 Nov 10; 27(32):5356-62. PubMed ID: 19805682
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.